MyPeptide

Research Use Only

Confirm access requirements before entering MyPeptide.

MyPeptide

Loading MyPeptide

Neurotrophic Signaling · 8 min read

Nootropic Peptides and Synaptogenesis: BDNF and TrkB Signalling

Researchers are studying peptides that promote BDNF expression, synaptogenesis, and neuroprotection — without dependency profiles in published studies.

Why nootropic peptide research is advancing beyond stimulant models.

Selank modulates GABA, serotonin, dopamine, and norepinephrine while increasing BDNF expression. Registered as a pharmaceutical in Russia since 2009. Published clinical studies show anxiety reduction and cognitive enhancement without sedation or dependence.

Each MyPeptide reference page is organized around product identity, documentation, and research context rather than medical claims, dosing instructions, or personal-use outcomes.

Use the related links on this page to move between the catalog, COA records, policy pages, and supporting research guides while staying within the research-use-only scope.

Batch documentation, product identity, and compliance context are kept close together so qualified purchasers can review the material before continuing through the storefront.

Article sections

  • BDNF, Synaptogenesis & Neuroprotection Research
  • Research Context
  • Anxiolytic Without Sedation (Selank)
  • Neurotrophin Enhancement (Semax)
  • Potent Synaptogenesis (Dihexa)